The ability of this drug to alter PKD1 expression has already been evaluated in animal models; using an orthotopic mouse model of breast cancer, Borges et al. showed that treatment with decitabine which restored PKD1 expression decreased the ability of breast cancer cells to metastasize to the lungs [29]. The gene discussed is PKD1; the disease is breast cancer.